Clinical Trial Update: An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice

View source ↗

Summary

This is a completed observational study evaluating Mircera for correcting renal anemia in dialysis patients during routine clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Anemia of Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Status: COMPLETED